🔎 Trials Near Me

Akèy › Sendwòm myelodisplastik › Kalifòni › Mountain View

Etid klinik pou Sendwòm myelodisplastik nan Mountain View, CA

9 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan ak bò kote Mountain View (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Ap rekriteFaz 1
  • Stanford Health Care, Stanford · 5 mi lwen
Laj 12 a 78 · Tout sèks · Mizajou Sep 29, 2026 · NCT03802695

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

Ap rekriteFaz 1
  • Lucille Packard Children's Hospital of Stanford University, Palo Alto · 5 mi lwen
18 Months – 39 Years · Tout sèks · Mizajou Aug 21, 2026 · NCT07573111

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

Ap rekriteFaz 1
  • Stanford University, Palo Alto · 5 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Aug 17, 2026 · NCT07302776

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Ap rekriteFaz 1/2
  • Stanford Cancer Institute, Palo Alto · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT05308264

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Ap rekriteFaz 1
  • Stanford University, Palo Alto · 5 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Jun 23, 2026 · NCT06551584

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Ap rekriteFaz 1/2
  • Stanford University, Palo Alto · 5 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04988555

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Stanford · 5 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Ap rekriteFaz 1
  • Stanford Cancer Center, Palo Alto · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2025 · NCT06501196

Etid Sendwòm myelodisplastik nan lòt vil

Lòt etid nan Mountain View

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.